Psychological Mobile App for Acute Myeloid Leukemia (AML) Patients
During their hospitalization for rigorous chemotherapy, patients with Acute Myeloid Leukemia (AML)...
Read More
Meeting Coverage
Multiple Sclerosis: Epstein-Barr Virus & Herpes Simplex Viruses
While the cause of multiple sclerosis (MS) was unknown, evidence showed that herpesviruses (HVs),...
Read More
Predicting Satisfaction With Psychosocial Life in Patients With MS
Health professionals have urged studies to measure people’s “happiness” by...
Read More
Recognition & Awareness of Spasticity in MS
Even though spasticity is prevalent, persons with multiple sclerosis (MS) with spasticity (PwMSS)...
Read More
Use of Disease-Modifying Therapies by Women With MS
Women of reproductive age were more likely to be diagnosed with multiple sclerosis (MS). Although...
Read MoreAccreditation Info CMSC 2022
The CMSC Annual Meeting provides a variety of credit offerings for attendees. Physician attendees can earn up to 18.0 AMA PRA Category 1 CreditsTM over the course of the meeting. Physician Assistants can earn up to 18.0 AAPA...
Read MoreCMSC 2022 COVID-19 and Masking Policy
Strongly Recommended In all conference and meeting rooms, you should wear your mask. Presenters and moderators/panelists can remove their mask when speaking. In standing room spaces, when engaged in extended conversation or are...
Read More
CMSC Independent Symposia
Advancing Advocacy in MS: Access to Affordable, High-Quality Care and Treatments Wednesday, June 1 at 8:00 am Delivering Patient-Centered, Equitable Multiple Sclerosis Care: The Latest Evidence and Real-World Perspectives...
Read More
ACTRIMS eBook
Focus on MS MAY 2022v2.indd
Read More
DMTs Lower Multiple Sclerosis Relapse Risk During Reproductive Therapy
In women with multiple sclerosis (MS) and clinically isolated syndrome (CIS), continuing disease...
Read More
Spinal Cord Atrophy Indicates “Silent Progression”
In patients in the earlier stages of MS, an accelerated rate of spinal cord atrophy can indicate...
Read More
Social Vulnerability Predicts Greater Multiple Sclerosis Disability
“It has previously been thought that [multiple sclerosis (MS)] is less common among non-European...
Read More
White Matter Iron Rim Lesions Predict Worse Disability in Multiple Sclerosis
“Identifying an accurate prognostic biomarker in individuals with multiple sclerosis (MS) is...
Read MorePlasma NfL levels associated with cardiovascular risk
Elevated levels of neurofilament light chain (NfL) are a known biomarker for neurodegeneration in conditions such as stroke, dementia, Multiple sclerosis, and Amyotrophic lateral sclerosis. A new study reveals that NfL may also...
Read More
Long-term Ozanimod Delivers No Evidence of Disease Activity in MS
Patients with relapsing multiple sclerosis (RMS) achieved No Evidence of Disease Activity (NEDA)...
Read More
Preoperative PET Scans Improve Management of Gynecologic Cancer
Preoperative PET scanning among patients with high-risk, clinical stage 1 endometrial cancer (EC)...
Read More
Immunotherapy Underutilized for Patients With Gynecologic Cancer
Immunotherapy is underutilized in patients with advanced endometrial cancer (EC), even though...
Read More
Increased Disparities Found in Cervical Cancer Screening Post-Pandemic
The COVID-19 pandemic had a major effect on access to gynecologic care for women of all races and...
Read More